These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

463 related items for PubMed ID: 18849076

  • 1. Poly(ethylene glycol)s generate complement activation products in human serum through increased alternative pathway turnover and a MASP-2-dependent process.
    Hamad I, Hunter AC, Szebeni J, Moghimi SM.
    Mol Immunol; 2008 Dec; 46(2):225-32. PubMed ID: 18849076
    [Abstract] [Full Text] [Related]

  • 2. Effect of supraphysiologic levels of C1-inhibitor on the classical, lectin and alternative pathways of complement.
    Nielsen EW, Waage C, Fure H, Brekke OL, Sfyroera G, Lambris JD, Mollnes TE.
    Mol Immunol; 2007 Mar; 44(8):1819-26. PubMed ID: 17101176
    [Abstract] [Full Text] [Related]

  • 3. Cooperation between MASP-1 and MASP-2 in the generation of C3 convertase through the MBL pathway.
    Møller-Kristensen M, Thiel S, Sjöholm A, Matsushita M, Jensenius JC.
    Int Immunol; 2007 Feb; 19(2):141-9. PubMed ID: 17182967
    [Abstract] [Full Text] [Related]

  • 4. The role of mannose-binding lectin-associated serine protease-3 in activation of the alternative complement pathway.
    Iwaki D, Kanno K, Takahashi M, Endo Y, Matsushita M, Fujita T.
    J Immunol; 2011 Oct 01; 187(7):3751-8. PubMed ID: 21865552
    [Abstract] [Full Text] [Related]

  • 5. Selective inhibition of the lectin pathway of complement with phage display selected peptides against mannose-binding lectin-associated serine protease (MASP)-1 and -2: significant contribution of MASP-1 to lectin pathway activation.
    Kocsis A, Kékesi KA, Szász R, Végh BM, Balczer J, Dobó J, Závodszky P, Gál P, Pál G.
    J Immunol; 2010 Oct 01; 185(7):4169-78. PubMed ID: 20817870
    [Abstract] [Full Text] [Related]

  • 6. Role of early lectin pathway activation in the complement-mediated killing of Trypanosoma cruzi.
    Cestari Idos S, Krarup A, Sim RB, Inal JM, Ramirez MI.
    Mol Immunol; 2009 Dec 01; 47(2-3):426-37. PubMed ID: 19783051
    [Abstract] [Full Text] [Related]

  • 7. Activation of the alternative complement pathway by mannose-binding lectin via a C2-bypass pathway.
    Tateishi K, Matsushita M.
    Microbiol Immunol; 2011 Nov 01; 55(11):817-21. PubMed ID: 21831201
    [Abstract] [Full Text] [Related]

  • 8. The down-stream effects of mannan-induced lectin complement pathway activation depend quantitatively on alternative pathway amplification.
    Harboe M, Garred P, Karlstrøm E, Lindstad JK, Stahl GL, Mollnes TE.
    Mol Immunol; 2009 Dec 01; 47(2-3):373-80. PubMed ID: 19800125
    [Abstract] [Full Text] [Related]

  • 9. Complement activation by sulfonated poly(ethylene glycol)-acrylate copolymers through alternative pathway.
    Jang HS, Ryu KE, Ahn WS, Chun HJ, Dal Park H, Park KD, Kim YH.
    Colloids Surf B Biointerfaces; 2006 Jul 01; 50(2):141-6. PubMed ID: 16797170
    [Abstract] [Full Text] [Related]

  • 10. Mannan-binding lectin-associated serine protease (MASP)-1 is crucial for lectin pathway activation in human serum, whereas neither MASP-1 nor MASP-3 is required for alternative pathway function.
    Degn SE, Jensen L, Hansen AG, Duman D, Tekin M, Jensenius JC, Thiel S.
    J Immunol; 2012 Oct 15; 189(8):3957-69. PubMed ID: 22966085
    [Abstract] [Full Text] [Related]

  • 11. MBL-associated serine protease-3 circulates in high serum concentrations predominantly in complex with Ficolin-3 and regulates Ficolin-3 mediated complement activation.
    Skjoedt MO, Palarasah Y, Munthe-Fog L, Jie Ma Y, Weiss G, Skjodt K, Koch C, Garred P.
    Immunobiology; 2010 Nov 15; 215(11):921-31. PubMed ID: 19939495
    [Abstract] [Full Text] [Related]

  • 12. A novel measurement method for activation of the lectin complement pathway via both mannose-binding lectin (MBL) and L-ficolin.
    Inoshita H, Matsushita M, Koide S, Kusaba G, Ishii M, Onda K, Gi MJ, Nakata M, Ohsawa I, Horikoshi S, Ohi H, Tomino Y.
    J Immunol Methods; 2009 Sep 30; 349(1-2):9-17. PubMed ID: 19699205
    [Abstract] [Full Text] [Related]

  • 13. Elucidation of the substrate specificity of the MASP-2 protease of the lectin complement pathway and identification of the enzyme as a major physiological target of the serpin, C1-inhibitor.
    Kerr FK, Thomas AR, Wijeyewickrema LC, Whisstock JC, Boyd SE, Kaiserman D, Matthews AY, Bird PI, Thielens NM, Rossi V, Pike RN.
    Mol Immunol; 2008 Feb 30; 45(3):670-7. PubMed ID: 17709141
    [Abstract] [Full Text] [Related]

  • 14. Complement activation by PEGylated single-walled carbon nanotubes is independent of C1q and alternative pathway turnover.
    Hamad I, Christy Hunter A, Rutt KJ, Liu Z, Dai H, Moein Moghimi S.
    Mol Immunol; 2008 Aug 30; 45(14):3797-803. PubMed ID: 18602161
    [Abstract] [Full Text] [Related]

  • 15. Activation of the lectin complement pathway in post-streptococcal acute glomerulonephritis.
    Hisano S, Matsushita M, Fujita T, Takeshita M, Iwasaki H.
    Pathol Int; 2007 Jun 30; 57(6):351-7. PubMed ID: 17539966
    [Abstract] [Full Text] [Related]

  • 16. Inhibition of liposome-induced complement activation by incorporated poly(ethylene glycol)-lipids.
    Bradley AJ, Devine DV, Ansell SM, Janzen J, Brooks DE.
    Arch Biochem Biophys; 1998 Sep 15; 357(2):185-94. PubMed ID: 9735159
    [Abstract] [Full Text] [Related]

  • 17. The control of the complement lectin pathway activation revisited: both C1-inhibitor and antithrombin are likely physiological inhibitors, while α2-macroglobulin is not.
    Paréj K, Dobó J, Závodszky P, Gál P.
    Mol Immunol; 2013 Jul 15; 54(3-4):415-22. PubMed ID: 23399388
    [Abstract] [Full Text] [Related]

  • 18. Serglycin inhibits the classical and lectin pathways of complement via its glycosaminoglycan chains: implications for multiple myeloma.
    Skliris A, Happonen KE, Terpos E, Labropoulou V, Børset M, Heinegård D, Blom AM, Theocharis AD.
    Eur J Immunol; 2011 Feb 15; 41(2):437-49. PubMed ID: 21268013
    [Abstract] [Full Text] [Related]

  • 19. Ficolins: complement-activating lectins involved in innate immunity.
    Matsushita M.
    J Innate Immun; 2010 Feb 15; 2(1):24-32. PubMed ID: 20375620
    [Abstract] [Full Text] [Related]

  • 20. Biological variations of MASP-3 and MAp44, two splice products of the MASP1 gene involved in regulation of the complement system.
    Degn SE, Jensen L, Gál P, Dobó J, Holmvad SH, Jensenius JC, Thiel S.
    J Immunol Methods; 2010 Sep 30; 361(1-2):37-50. PubMed ID: 20673767
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 24.